A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor

Evolutionary and Genomic Insights into Clostridioides difficile Sequence Type 11: a Diverse Zoonotic and Antimicrobial-Resistant Lineage of Global One Health Importance

(2019) Daniel R. Knight et al.   mBio

The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan

(2018) Marcela Krutova et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Characterization of Bacteriophages Infecting Clinical Isolates of Clostridium difficile

(2018) Wichuda Phothichaisri et al.   Frontiers in Microbiology

New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability

(2017) Joseph A. Kirk et al.   Science Translational Medicine

Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prévot 1938

(2016) Paul A. Lawson et al.   ANAEROBE

Potentially hypervirulent Clostridium difficile PCR ribotype 078 lineage isolates in pigs and possible implications for humans in Taiwan

(2016) Ying-Chen Wu et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

PHASTER: a better, faster version of the PHAST phage search tool

(2016) David Arndt et al.   NUCLEIC ACIDS RESEARCH

Two Novel Myoviruses from the North of Iraq Reveal Insights into Clostridium difficile Phage Diversity and Biology

(2016) Srwa Rashid et al.   Viruses-Basel

More Is Better: Selecting for Broad Host Range Bacteriophages

(2016) Alexa Ross et al.   Frontiers in Microbiology

Characteristics of theClostridium difficilecell envelope and its importance in therapeutics

(2016) Joseph A. Kirk et al.   Microbial Biotechnology

Bacteriophage Combinations Significantly Reduce Clostridium difficile GrowthIn Vitroand ProliferationIn Vivo

(2015) Janet Y. Nale et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Burden of Clostridium difficile Infection in the United States

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

A Modified R-Type Bacteriocin Specifically Targeting Clostridium difficile Prevents Colonization of Mice without Affecting Gut Microbiota Diversity

(2015) Dana Gebhart et al.   mBio

New Drugs and Strategies for Management of Clostridium difficile Colitis

(2013) J. T. Higa et al.   JOURNAL OF INTENSIVE CARE MEDICINE

Recombinational Switching of the Clostridium difficile S-Layer and a Novel Glycosylation Gene Cluster Revealed by Large-Scale Whole-Genome Sequencing

(2012) Kate E. Dingle et al.   JOURNAL OF INFECTIOUS DISEASES

Clostridium difficileHas Two Parallel and Essential Sec Secretion Systems

(2011) Robert P. Fagan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A mariner-Based Transposon System for In Vivo Random Mutagenesis of Clostridium difficile

(2009) S. T. Cartman et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain

(2009) Jennifer R. O'Connor et al.   GASTROENTEROLOGY

Bacteriophage-Mediated Toxin Gene Regulation in Clostridium difficile

(2009) R. Govind et al.   JOURNAL OF VIROLOGY

Structural insights into the molecular organization of the S-layer fromClostridium difficile

(2009) Robert P. Fagan et al.   MOLECULAR MICROBIOLOGY

Emergence ofClostridium difficileInfection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078

(2008) Abraham Goorhuis et al.   CLINICAL INFECTIOUS DISEASES

Molecular Characterization of a Clostridium difficile Bacteriophage and Its Cloned Biologically Active Endolysin

(2008) M. J. Mayer et al.   JOURNAL OF BACTERIOLOGY

Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated Diarrhea

(2008) Ju Young Chang et al.   JOURNAL OF INFECTIOUS DISEASES